SPP1 facilitates sorafenib resistance in hepatocellular carcinoma by upregulating aerobic glycolysis in endothelial cells.

Ye W, Chen T, Li Y, Luan J, Yang K, Wang S

Open source

DOI
10.3724/abbs.2025245
Published
2026 Nov 25
Container
Acta biochimica et biophysica Sinica
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3724/abbs.2025245,
  title = {SPP1 facilitates sorafenib resistance in hepatocellular carcinoma by upregulating aerobic glycolysis in endothelial cells.},
  author = {Ye W and Chen T and Li Y and Luan J and Yang K and Wang S},
  year = {2026},
  journal = {Acta biochimica et biophysica Sinica},
  doi = {10.3724/abbs.2025245},
  url = {https://doi.org/10.3724/abbs.2025245}
}

RIS

TY  - JOUR
TI  - SPP1 facilitates sorafenib resistance in hepatocellular carcinoma by upregulating aerobic glycolysis in endothelial cells.
AU  - Ye W
AU  - Chen T
AU  - Li Y
AU  - Luan J
AU  - Yang K
AU  - Wang S
PY  - 2026
JO  - Acta biochimica et biophysica Sinica
DO  - 10.3724/abbs.2025245
UR  - https://doi.org/10.3724/abbs.2025245
ER  - 

APA

W, Y., T, C., Y, L., J, L., K, Y., & S, W. (2026). SPP1 facilitates sorafenib resistance in hepatocellular carcinoma by upregulating aerobic glycolysis in endothelial cells.. Acta biochimica et biophysica Sinica. https://doi.org/10.3724/abbs.2025245

Source records